ATNX

Athenex Stock Price

12.10
-0.05 (-0.41%)
Upgrade to Real-Time
Afterhours (Closed)
12.10
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Athenex Inc ATNX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -0.41% 12.10 00:00:04
Close Price Low Price High Price Open Price Previous Close
12.10 12.01 12.65 12.22 12.15
Bid Price Ask Price Spread News
12.12 13.90 1.78 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,789 616,418 $ 12.29 $ 7,578,109 1,207,890 5.63 - 22.00
Last Trade Time Type Quantity Stock Price Currency
17:44:13 10 $ 12.10 USD

Athenex Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.11B 91.73M 71.49M $ 101.23M $ -83.93M -1.68 -13.22
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Athenex News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ATNX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week12.8513.7811.72512.28673,918-0.75-5.84%
1 Month12.6115.2410.7912.351,558,850-0.51-4.04%
3 Months13.3615.509.9712.09820,982-1.26-9.43%
6 Months7.6115.506.9611.45693,3024.4959.0%
1 Year12.6222.005.6312.22823,918-0.52-4.12%
3 Years17.6122.005.6313.72525,395-5.51-31.29%
5 Years12.0022.005.6313.81495,7830.100.83%

Athenex Description

Athenex Inc is a global biopharmaceutical company. It is dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer. The company's operating segment includes the Oncology Innovation Platform; Global Supply Chain Platform and Commercial Platform. It generates maximum revenue from the Commercial Platform segment. Commercial Platform segment includes APD, which focuses on the manufacturing, distribution, and sales of specialty pharmaceuticals. Geographically, it derives a majority of revenue from the United States and also has a presence in Spain; Austria; India; China; the United Kingdom and Other foreign countries.


Your Recent History
NASDAQ
ATNX
Athenex
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.